Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

795 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ramucirumab: a novel antiangiogenic agent.
Wadhwa R, Taketa T, Sudo K, Blum-Murphy M, Ajani JA. Wadhwa R, et al. Among authors: ajani ja. Future Oncol. 2013 Jun;9(6):789-95. doi: 10.2217/fon.13.68. Future Oncol. 2013. PMID: 23718298
A nomogram associated with high probability of malignant nodes in the surgical specimen after trimodality therapy of patients with oesophageal cancer.
Hayashi Y, Xiao L, Suzuki A, Blum MA, Sabloff B, Taketa T, Maru DM, Welsh J, Lin SH, Weston B, Lee JH, Bhutani MS, Hofstetter WL, Swisher SG, Ajani JA. Hayashi Y, et al. Among authors: ajani ja. Eur J Cancer. 2012 Dec;48(18):3396-404. doi: 10.1016/j.ejca.2012.06.020. Epub 2012 Jul 31. Eur J Cancer. 2012. PMID: 22853875 Free PMC article.
Outcome of trimodality-eligible esophagogastric cancer patients who declined surgery after preoperative chemoradiation.
Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Taketa T, et al. Among authors: ajani ja. Oncology. 2012;83(5):300-4. doi: 10.1159/000341353. Epub 2012 Sep 4. Oncology. 2012. PMID: 22964903 Free PMC article.
Surveillance for esophageal cancer: does it make sense?
Murphy MA, Taketa T, Sudo K, Lee JH, Ajani JA. Murphy MA, et al. Among authors: ajani ja. J Natl Compr Canc Netw. 2012 Dec 1;10(12):1590-2. doi: 10.6004/jnccn.2012.0161. J Natl Compr Canc Netw. 2012. PMID: 23221793 No abstract available.
Modern oncological approaches to gastric adenocarcinoma.
Wadhwa R, Taketa T, Sudo K, Blum MA, Ajani JA. Wadhwa R, et al. Among authors: ajani ja. Gastroenterol Clin North Am. 2013 Jun;42(2):359-69. doi: 10.1016/j.gtc.2013.01.011. Epub 2013 Mar 1. Gastroenterol Clin North Am. 2013. PMID: 23639645 Review.
Incidence of brain metastases after trimodality therapy in patients with esophageal or gastroesophageal cancer: implications for screening and surveillance.
Wadhwa R, Taketa T, Correa AM, Sudo K, Campagna MC, Blum MA, Komaki R, Skinner H, Lee JH, Bhutani MS, Weston B, Maru DM, Rice DC, Swisher S, Hofstetter WL, Ajani JA. Wadhwa R, et al. Among authors: ajani ja. Oncology. 2013;85(4):204-7. doi: 10.1159/000354736. Epub 2013 Sep 19. Oncology. 2013. PMID: 24051869
795 results